All.Can Patient Survey

68 Belgium About this survey in Belgium The survey in Belgium was conducted in partnership with All.Can Belgium. Data collection took place from 28 August – 30 November 2018. A total of 391 people took part in the Belgian survey. Respondent profile • Cancer type: breast 47% ; haematological 9% ; bowel/colorectal 7% ; lung 7% ; other (various cancer types, all <5%) 29% • Gender: female 75% ; male 25% • Age: 0–24 1% ; 25–64 61% ; 65+ 34% ; not specified 3% • Language: Dutch 63% ; French 37% ; German 0.26% Where did inefficiencies occur most? • Dealing with ongoing side effects: 28% • My initial cancer diagnosis: 17% • Getting the right treatment for my cancer: 15% i Belgian Cancer Registry. Cancer burden 2004-2013. Available online at https://kankerregister.org/media/docs/publications/BCR_ publicatieCancerBurden2016_web160616.pdf ii Belgian Cancer Registry. Annual tables. Available online at https://kankerregister.org/default.aspx?PageId=643 ’My son’s diagnostic process was very fast and efficient. Even after our first emergency visit, the follow-up (to make sure we did not stop the medical exams) was impeccable.’ ‘I had to ask for psychological help myself. This wasn’t the priority of the treating physician, but I am very glad that I insisted. The doctor was not against it, but didn’t think it was a priority!’ An estimated 3% of the Belgian population were living with and beyond cancer between 2004 and 2013. i There are over 70,000 new cases of cancer each year. ii